Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)

Giuseppe Mancia, Helmut Schumacher, Josep Redon, Paolo Verdecchia, Roland Schmieder, Garry Jennings, Khalid Yusoff, Lars Ryden, G. Lisheng Liu, Koon Teo, Peter Sleight, Salim Yusuf

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

BACKGROUND-: Hypertension treatment guidelines recommend that blood pressure (BP) be lowered to 75%) in which BP was reduced to

Original languageEnglish
Pages (from-to)1727-1736
Number of pages10
JournalCirculation
Volume124
Issue number16
DOIs
Publication statusPublished - Oct 18 2011

Fingerprint

Ramipril
Guidelines
Blood Pressure
Kidney
Incidence
Hypertension
telmisartan

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). / Mancia, Giuseppe; Schumacher, Helmut; Redon, Josep; Verdecchia, Paolo; Schmieder, Roland; Jennings, Garry; Yusoff, Khalid; Ryden, Lars; Liu, G. Lisheng; Teo, Koon; Sleight, Peter; Yusuf, Salim.

In: Circulation, Vol. 124, No. 16, 18.10.2011, p. 1727-1736.

Research output: Contribution to journalArticle

Mancia, G, Schumacher, H, Redon, J, Verdecchia, P, Schmieder, R, Jennings, G, Yusoff, K, Ryden, L, Liu, GL, Teo, K, Sleight, P & Yusuf, S 2011, 'Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)', Circulation, vol. 124, no. 16, pp. 1727-1736. https://doi.org/10.1161/CIRCULATIONAHA.110.008870
Mancia, Giuseppe ; Schumacher, Helmut ; Redon, Josep ; Verdecchia, Paolo ; Schmieder, Roland ; Jennings, Garry ; Yusoff, Khalid ; Ryden, Lars ; Liu, G. Lisheng ; Teo, Koon ; Sleight, Peter ; Yusuf, Salim. / Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). In: Circulation. 2011 ; Vol. 124, No. 16. pp. 1727-1736.
@article{ae33d647eb91466d9418f83058e68751,
title = "Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)",
abstract = "BACKGROUND-: Hypertension treatment guidelines recommend that blood pressure (BP) be lowered to 75{\%}) in which BP was reduced to",
author = "Giuseppe Mancia and Helmut Schumacher and Josep Redon and Paolo Verdecchia and Roland Schmieder and Garry Jennings and Khalid Yusoff and Lars Ryden and Liu, {G. Lisheng} and Koon Teo and Peter Sleight and Salim Yusuf",
year = "2011",
month = "10",
day = "18",
doi = "10.1161/CIRCULATIONAHA.110.008870",
language = "English",
volume = "124",
pages = "1727--1736",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "16",

}

TY - JOUR

T1 - Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)

AU - Mancia, Giuseppe

AU - Schumacher, Helmut

AU - Redon, Josep

AU - Verdecchia, Paolo

AU - Schmieder, Roland

AU - Jennings, Garry

AU - Yusoff, Khalid

AU - Ryden, Lars

AU - Liu, G. Lisheng

AU - Teo, Koon

AU - Sleight, Peter

AU - Yusuf, Salim

PY - 2011/10/18

Y1 - 2011/10/18

N2 - BACKGROUND-: Hypertension treatment guidelines recommend that blood pressure (BP) be lowered to 75%) in which BP was reduced to

AB - BACKGROUND-: Hypertension treatment guidelines recommend that blood pressure (BP) be lowered to 75%) in which BP was reduced to

UR - http://www.scopus.com/inward/record.url?scp=80054959783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054959783&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.110.008870

DO - 10.1161/CIRCULATIONAHA.110.008870

M3 - Article

C2 - 21947289

AN - SCOPUS:80054959783

VL - 124

SP - 1727

EP - 1736

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 16

ER -